•  
  •  
  •  
  •  

2025-12-28 02:12:34

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Provigil Surveillance Ltd receives LoA from IRCTC
  • Bazel International Ltd recommends 1:1 bonus issue
  • TMB Launches Online EPF Payment Facility
  • Settlement of land disputes between NBCC India Ltd and the Government, NCT of Delhi
  • Laxmi Organic Industries Ltd clarifies on Lote facility

Keywords Selected:  Ibuprofen

Stock Report

  • IOL Chemicals and Pharmaceuticals Ltd receives approval CDE of NMPA, China for Ibuprofen
  • Relonchem Ltd receives Marketing Authorization for Ibuprofen and Paracetamol tablets
  • Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
  • Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio
  • SMS Pharma receives EDQM Certification to supply to Ibuprofen in Europe
  • Glenmark Pharmaceuticals receives ANDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg
  • Granules India Ltd announces approval for the Store Brand OTC Equivalent of AdvilĀ® Dual Action Tablets
  • Marksans announces FDA approval of OTC equivalent of Advil Dual Action Tablets
  • SMS Pharmaceuticals Ltd receives Certificate of Suitability approval for Ibuprofen by EDQM
  • Marksans Pharma Ltd recalls Kroger brand Aspirin and Ibuprofen
  • Strides receives USFDA approval for Ibuprofen OTC Oral Suspension
  • Strides receives USFDA approval for Ibuprofen Oral Suspension

Latest Post

  • Provigil Surveillance Ltd receives LoA from IRCTC
  • Bazel International Ltd recommends 1:1 bonus issue
  • TMB Launches Online EPF Payment Facility
  • Settlement of land disputes between NBCC India Ltd and the Government, NCT of Delhi
  • Laxmi Organic Industries Ltd clarifies on Lote facility


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024